aztreonam has been researched along with Pneumonia, Bacterial in 7 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Pneumonia, Bacterial: Inflammation of the lung parenchyma that is caused by bacterial infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this clinician-therapeutic drug monitoring (TDM) consultant interaction, the authors describe the use of TDM in an 11-year-old female patient with cystic fibrosis receiving ceftazidime/avibactam and aztreonam for the treatment of persistent pulmonary exacerbations caused by Stenotrophomonas pneumonia." | 8.02 | Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study. ( Cowart, MC; Ferguson, CL, 2021) |
| "In this clinician-therapeutic drug monitoring (TDM) consultant interaction, the authors describe the use of TDM in an 11-year-old female patient with cystic fibrosis receiving ceftazidime/avibactam and aztreonam for the treatment of persistent pulmonary exacerbations caused by Stenotrophomonas pneumonia." | 4.02 | Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study. ( Cowart, MC; Ferguson, CL, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cowart, MC | 1 |
| Ferguson, CL | 1 |
| Dupont, H | 1 |
| Marciniak, S | 1 |
| Zogheib, E | 1 |
| Mammeri, H | 1 |
| Friggeri, A | 1 |
| Ammenouche, N | 1 |
| Levrard, M | 1 |
| Airapetian, N | 1 |
| Tinturier, F | 1 |
| Mahjoub, Y | 1 |
| Bae, S | 1 |
| Kim, MC | 1 |
| Park, SJ | 1 |
| Kim, HS | 1 |
| Sung, H | 1 |
| Kim, MN | 1 |
| Kim, SH | 1 |
| Lee, SO | 1 |
| Choi, SH | 1 |
| Woo, JH | 1 |
| Kim, YS | 1 |
| Chong, YP | 1 |
| Wunderink, RG | 1 |
| Cammarata, SK | 1 |
| Oliphant, TH | 1 |
| Kollef, MH | 1 |
| Frei, CR | 1 |
| Burgess, DS | 1 |
| Wang, JX | 1 |
| Liu, YN | 1 |
| Raad, I | 1 |
| Hachem, R | 1 |
| Hanna, H | 1 |
| Abi-Said, D | 1 |
| Bivins, C | 1 |
| Walsh, G | 1 |
| Thornby, J | 1 |
| Whimbey, E | 1 |
| Huaringa, A | 1 |
| Sukumaran, A | 1 |
2 trials available for aztreonam and Pneumonia, Bacterial
| Article | Year |
|---|---|
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents | 2003 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Comb | 2001 |
5 other studies available for aztreonam and Pneumonia, Bacterial
| Article | Year |
|---|---|
Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Ceftazidime; Child; Cystic Fibrosis; Drug Co | 2021 |
Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Re | 2015 |
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cef | 2016 |
Continuous infusion beta-lactams for intensive care unit pulmonary infections.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simu | 2005 |
[Antibiotic treatment for pneumonia caused by Flavobacterium meningosepticum].
Topics: Aged; Aztreonam; Cefsulodin; Ciprofloxacin; Drug Therapy, Combination; Female; Flavobacterium; Gram- | 1994 |